Risk factor
Strong trading liquidity
Profitability factor
Very strong margins and returns
About
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases....
Company Valuation
Based on key historical and expected multiples, the stock is greatly overvalued relative to its peers. Specifically, the stock is 'expensive' on P/E, overvalued on EV/EBI
Target Price
The average target price of EW is 96 and suggests 24% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increase o
Buy
Sell